INTANGIBLE ASSETS (Details) - USD ($) |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Dec. 31, 2019 |
|
Goodwill and Intangible Assets Disclosure [Abstract] | |||||
Patent costs | $ 155,507 | $ 155,507 | $ 127,593 | ||
License costs | 241,909 | 241,909 | |||
Accumulated amortization of patent costs | 3,169 | 3,169 | $ 1,249 | ||
Accumulated amortization of license costs | 11,232 | 11,232 | |||
Amortization expense | $ 640 | $ 313 | $ 13,152 | $ 742 |
X | ||||||||||
- Definition Accumulated amortization of license costs. No definition available.
|
X | ||||||||||
- Definition Accumulated amortization of patent costs. No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the capitalized costs to acquire rights under a license arrangement (for example, to sell specified products in a specified territory) having an indefinite period of benefit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|